Friday, October 15, 2021 9:00 AM to 1:00 PM
Wilentz Health and Corporate Law Co-Chair, Past Chair of the NJSBA Health Law Section, and NJSBA Trustee, Michael F. Schaff, will moderate the NJICLE’s 2021 Health Law Symposium, which will address the latest developments relating to case law, regulatory changes, DOH developments, and cannabis and post-acute care. Wilentz shareholder, current NJSBA Health Law Section Chair, and NJSBA Cannabis Law Committee Co-Chair, Lisa Gora, will present “Medicinal Cannabis-The Legal and Practical Considerations for Physicians, Hospitals and Post-Acute Care Facilities.” The session will address the regulatory changes in New Jersey’s cannabis industry and the path for healthcare providers to offer medicinal options in post-acute care.
The discussion agenda includes:
- Year in Review-Cases
- Regulatory Updates
- Department of Health Update
- DEA Form 104
This program has been approved by the Board on Continuing Legal Education of the Supreme Court of New Jersey for 4.2 of total CLE credit.
*Cannabis Law Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance. Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy, regardless of any state law that may authorize certain marijuana activity. Compliance with state marijuana law does not equal compliance with federal law. Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.